Journal profile · Pathology
Neuropathology and Applied Neurobiology
ISSN 0305-1846 · eISSN 1365-2990 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1975
Neuropathology and Applied Neurobiology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 2.95; hybrid open access; APC about USD 4,480; median 161 days to acceptance (74 articles, last 24 months); community-reported acceptance: moderate; 64 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neuropathology and Applied Neurobiology is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Alzheimer's disease research and treatments, Glioma Diagnosis and Treatment and Neurological diseases and metabolism, together about 26.1% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Neuropathology and Applied Neurobiology is an international journal, sponsored by the British Neuropathological Society, for the publication of original papers and authoritative reviews on the disease mechanisms and the clinical pathology of disorders of brain, nerve and muscle. It welcomes contributions with a tissue-based focus on all relevant aspects of neurological disease, from experimental neurobiology to pathological diagnosis, regardless of methodology. Multidisciplinary papers are particularly welcomed. The journal publishes original data papers, authoritative reviews, short reviews and commentaries. Case reports that contain significant novel findings may be published as items of scientific correspondence, and the journal welcomes constructive and interesting letters. Information for contributors is available by clicking on this link. Copyright for articles resides with the publishers from whom, through the Editor, permission for reproduction etc. should be sought.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Tom JacquesPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 4, Netherlands 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alzheimer's disease research and treatmentsMedicine10.8%
- Glioma Diagnosis and TreatmentMedicine9.1%
- Neurological diseases and metabolismNeuroscience6.2%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.1%
- Neurogenesis and neuroplasticity mechanismsNeuroscience5.8%
- Parkinson's Disease Mechanisms and TreatmentsMedicine5.6%
- Amyotrophic Lateral Sclerosis ResearchMedicine5.5%
- Prion Diseases and Protein MisfoldingBiochemistry, Genetics and Molecular Biology4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pathology | Zone 2 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.95LetPub ·
- Impact factor (publisher) 2025
- 3Publisher website ·
- CiteScore 2026-06
- 7.7LetPub ·
- CiteScore (publisher) 2025
- 7.7Publisher website ·
- SJR 2026-06
- 1.51LetPub ·
- SNIP 2026-06
- 0.94LetPub ·
- h-index
- 86LetPub ·
- h-index
- 144OpenAlex ·
- i10-index
- 2,197OpenAlex ·
- 2-year mean citedness
- 2.89OpenAlex ·
- Self-citation rate
- 3.3%LetPub ·
- Share of gold OA articles
- 63.69%LetPub ·
Volume
- Articles per year
- 42LetPub ·
- Articles per year (publisher) 2025
- 44Publisher website ·
- Downloads per year (publisher) 2025
- 265,606Publisher website ·
Articles by year OpenAlex count · 4,210 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 41 | 13 |
| 2025 | 64 | 42 | 92 |
| 2024 | 72 | 55 | 455 |
| 2023 | 82 | 66 | 480 |
| 2022 | 95 | 55 | 1,175 |
| 2021 | 109 | 78 | 2,339 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
161 daysMedian, submission to acceptance · P25–P75 107 days – 203 days
- Acceptance to online
- median 15 days (74 articles)
- Submission to online
- median 180 days
- Sample
- 74 articles with submission and acceptance dates (122 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher) 2025
- 13%Publisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 173 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Open peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,480 / EUR 3,750 / GBP 3,010 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 5,000 words
Article types accepted1, with length limits
- reviewtity of any patients should be omitted. Reviews Reviews should be on a topic of current interest and no longer than 6000 words. They should be interestingly wri…main text ≤ 6,000 words
Policy excerpts from the journal's websiteConflicts of interest
- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section 'Conflict of Interest' in the Best Practice Guidelines on Publishing Ethics. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement. ApprovalsIn all original work the authors should s…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1975
- ISSN
- 0305-1846
- Electronic ISSN
- 1365-2990
- Latest issue on the website
- Volume 52, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Neuropathology and Applied Neurobiology
What CAS zone is Neuropathology and Applied Neurobiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neuropathology and Applied Neurobiology is in Zone 2 of Medicine, and in Zone 2 of the minor category Neurosciences / Pathology / Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuropathology and Applied Neurobiology?
The latest impact factor listed by LetPub is 2.95; CiteScore 7.7, h-index 144.
How long does peer review take at Neuropathology and Applied Neurobiology?
Based on the dates recorded on 74 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 161 days (interquartile range 107–203 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 13% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Neuropathology and Applied Neurobiology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 5,000 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Neuropathology and Applied Neurobiology based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (4) and Netherlands (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Neuropathology and Applied Neurobiology?
According to LetPub and DOAJ records, Neuropathology and Applied Neurobiology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Neuropathology and Applied Neurobiology open access, and what is the APC?
Neuropathology and Applied Neurobiology is a hybrid journal. For open-access publication: APC about USD 4,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .